Tuberculosis: A persistent threat, yet clinical trials show promise
Researchers at The Institute advance the search for preventive treatments for multidrug-resistant TB
Semaglutide—known as Ozempic—can be beneficial to people with type 1 diabetes
A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose...
Discovery of a commensal fungus that shapes anti-parasite and allergic immune responses
This groundbreaking discovery opens up new opportunities to study the role of host-fungus interactions in intestinal...
Two researchers from The Institute appointed to the Order of Canada
Dr. Nada Jabado and Dr. Sam Shemie, both physicians at the Montreal Children's Hospital as well as scientists, were recognized for their exceptional...
Universal genetic testing of breast cancer patients could help many
McGill-led study shows casting a wider net can identify candidates for advanced therapies who might otherwise have been missed
Pregnancy enhances natural immunity to block severe flu
Scientists discover a natural flu defense mechanism that activates in the nasal cavity during pregnancy
Canada's Top 40 Research Hospitals: number 1 in Quebec, number 3 in the country!
Thanks to the researchers, trainees and staff at The Institute, the MUHC maintains its leadership position in the...
MUHC patients among the first in the world to enroll in mRNA individualized treatment trials for lung cancer
The Research Institute of the McGill University Health Centre is at...
Discovery of new genes for molar pregnancies sheds light on their increased incidence in women aged 35 and over
Major advances made at the RI-MUHC could help improve counselling...
International awards for three cardiovascular health researchers from the RI-MUHC
Drs. Rhian Touyz and Mariane Bertagnolli were honoured by the International Society of Hypertension...